Caleres, Inc.
NYSE:CALApparel - Footwear & Accessories
+$0.74 today
- Market cap
- $474.44M
- Beta
- 0.74
- P/E (TTM)
- 1535.9
- EPS (TTM)
- $0.01
- Dividend yield
- 2.12%
Volume 0.45M
Average 0.70M
CAL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Caleres, Inc.NYSE: CAL
Research & Development · Q1 FY2026 · quarter ended May 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-31 | 0 | — |
| FY2024 | 2025-02-01 | 0 | — |
| FY2023 | 2024-02-03 | 0 | — |
| FY2022 | 2023-01-28 | 0 | — |
| FY2021 | 2022-01-29 | 0 | — |
Research & Development vs competitors
How CAL compares with its peers on the latest reported figures
- CAL's LTM May 2026 research & development of $0 is the 5th highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CAL, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $58.41M | -9.9% | -15.9% | 130.3% | |
| LTM Mar 2026 | $39.36M | +32.7% | — | 5.7% | |
| LTM Mar 2026 | $37.91M | -8.1% | -30.6% | 651.5% | |
| LTM Mar 2026 | $7.36M | +4.8% | +1.6% | 2.1% | |
| LTM May 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM May 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM May 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CAL) | $0 | -1.7% | -15.9% | 0.0% | |
Competitors are the stored peer set for CAL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jan 2022 | FY2022 Jan 2023 | FY2023 Feb 2024 | FY2024 Feb 2025 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 2.78B | 2.97B | 2.82B | 2.72B | 2.76B |
| Cost of Revenue | 1.55B | 1.68B | 1.55B | 1.5B | 1.57B |
| Gross Profit | 1.23B | 1.28B | 1.26B | 1.22B | 1.18B |
| Gross Margin | 44.2% | 43.3% | 44.8% | 44.9% | 43.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.01B | 1.07B | 1.06B | 1.07B | 1.14B |
| Operating Expenses | 1.02B | 1.07B | 1.06B | 1.07B | 1.16B |
| Depreciation & Amortization | 52.33M | 49.01M | 53.28M | 56.43M | 64.58M |
| EBITDA | 257.08M | 276.31M | 253.95M | 205.54M | 70.82M |
| EBITDA Margin | 9.3% | 9.3% | 9.0% | 7.5% | 2.6% |
| Operating Income | 205.81M | 214.33M | 201.31M | 149.86M | 28.98M |
| Operating Margin | 7.4% | 7.2% | 7.1% | 5.5% | 1.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 30.93M | 14.26M | 19.34M | 13.96M | 18.46M |
| Other Income / Expenses | (16.56M) | (1.29M) | (19.99M) | (14.7M) | (41.2M) |
| Income Before Tax | 189.24M | 213.03M | 181.32M | 135.16M | (12.22M) |
| Pre-Tax Margin | 6.8% | 7.2% | 6.4% | 5.0% | -0.4% |
| Income Tax Expense | 51.08M | 33.34M | 9.49M | 29.06M | (2.35M) |
| Net Income | 137.02M | 181.74M | 163.87M | 107.26M | (7.05M) |
| Net Margin | 4.9% | 6.1% | 5.8% | 3.9% | -0.3% |
| EPS (Basic) | 3.59 | 4.98 | 4.80 | 3.10 | (0.22) |
| EPS (Diluted) | 3.56 | 4.92 | 4.80 | 3.09 | (0.22) |
| Weighted Avg Shares | 36.74M | 34.93M | 34.14M | 33.4M | 32.52M |
| Weighted Avg Shares (Diluted) | 37.1M | 35.41M | 34.15M | 33.51M | 32.64M |
Caleres, Inc.
NYSE:CAL
Intrinsic Alpha fair value
Locked
Current Price
$13.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.